MELINA LANZAR: Open Payments
NPI 1023883642 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $180 |
| AstraZeneca Pharmaceuticals LP | 3 | $162 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $110 |
| SANOFI-AVENTIS U.S. LLC | 1 | $105 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| QIAGEN, LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: REXULTI, BREZTRI, TZIELD, BIJUVA, Auvelity, AIRSUPRA, CAPLYTA, FARXIGA.
Industry payments across CA — which companies pay providers there.
